Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - betamethasone; calcipotriol - gel - 50 microgram/g +0.5 milligram(s)/gram - calcipotriol, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - calcipotriol; betamethasone - ointment - 50microg/g + 0.5 milligram(s)/gram - other antipsoriatics for topical use; calcipotriol, combinations

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - calcipotriol, quantity: 52.2 microgram/g; betamethasone dipropionate, quantity: 643 microgram/g (equivalent: betamethasone, qty microgram/g) - ointment - excipient ingredients: dl-alpha-tocopherol; oleyl alcohol; liquid paraffin; white soft paraffin - indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy.

Malta - English - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - calcipotriol monohydrate, betamethasone dipropionate - ointment - calcipotriol monohydrate 50 µg/g betamethasone dipropionate 0.5 mg/g - antipsoriatics

Canada - English - Health Canada

teva canada limited - betamethasone (betamethasone dipropionate); calcipotriol - ointment - 0.5mg; 50mcg - betamethasone (betamethasone dipropionate) 0.5mg; calcipotriol 50mcg - anti-inflammatory agents

Canada - English - Health Canada

taro pharmaceuticals inc - calcipotriol (calcipotriol monohydrate); betamethasone (betamethasone dipropionate) - gel - 50mcg; 0.5mg - calcipotriol (calcipotriol monohydrate) 50mcg; betamethasone (betamethasone dipropionate) 0.5mg

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg; calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg - topical ointment - active: betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg excipient: d-alpha tocoferol liquid paraffin oleyl alcohol white soft paraffin - calcipotriol and betamethasone ointment is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in patients 18 years and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - betamethasone dipropionate 0.643 mg/g equivalent to betamethasone base 0.500 mg/g; calcipotriol 0.05 mg/g;   - topical ointment - active: betamethasone dipropionate 0.643 mg/g equivalent to betamethasone base 0.500 mg/g calcipotriol 0.05 mg/g   excipient: butylated hydroxytoluene liquid paraffin polyoxypropylene monostearyl ether white soft paraffin - calcipotriol /betamethasone (teva) is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in adult patients 18 years and older.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dermapharm ag - calcipotriol monohydrate 0,052 mg/g - eq. calcipotriol 0,05 mg/g; betamethasone dipropionate 0,643 mg/g - eq. betamethasone 0,5 mg/g - ointment - 50 µg/g - 0,5 mg/g - calcipotriol monohydrate 0.052 mg/g; betamethasone dipropionate 0.643 mg/g - calcipotriol, combinations

Australia - English - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - calcipotriol, quantity: 50 microgram/g; betamethasone dipropionate (equivalent: betamethasone, qty 500 microgram/g) - gel - excipient ingredients: nitrogen; hydrogenated castor oil; polyoxypropylene-11 stearyl ether; butylated hydroxytoluene; liquid paraffin; dl-alpha-tocopherol - topical treatment of scalp psoriasis. topical treatment of mild to moderate plaque psoriasis on the body in adults.